Dr. Reddy’s recalls Sapropterin Dihydrochloride oral solution powder in U.S. due to ‘sub potency’

The issue was discovered during an accelerated stability test in addition to customer complaints.

from Business News, Finance News, Market News, Stock News, BSE, NSE, Nifty | The Hindu